Correlation Between Abcellera Biologics and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Abcellera Biologics and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Apogee Therapeutics,.
Diversification Opportunities for Abcellera Biologics and Apogee Therapeutics,
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Abcellera and Apogee is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Apogee Therapeutics,
Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.27 times more return on investment than Apogee Therapeutics,. However, Abcellera Biologics is 1.27 times more volatile than Apogee Therapeutics, Common. It trades about 0.04 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.25 per unit of risk. If you would invest 289.00 in Abcellera Biologics on August 28, 2024 and sell it today you would earn a total of 6.00 from holding Abcellera Biologics or generate 2.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abcellera Biologics vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| Abcellera Biologics |
| Apogee Therapeutics, |
Abcellera Biologics and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcellera Biologics and Apogee Therapeutics,
The main advantage of trading using opposite Abcellera Biologics and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
| Apogee Therapeutics, vs. Bridgford Foods | Apogee Therapeutics, vs. Tyson Foods | Apogee Therapeutics, vs. Iridium Communications | Apogee Therapeutics, vs. Natural Alternatives International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |